We are live on !
Find out more
Bard Associates Portfolio holdings
AUM
$451M
Turnover
30.43%
1-Year Est. Return
66.6%
This Fund
S&P 500
This Quarter Est. Return
+23.7%
1 Year Est. Return
+66.6%
3 Year Est. Return
+240.62%
5 Year Est. Return
+264%
10 Year Est. Return
+1,454.38%
AUM
$451M
AUM Growth
+$52.1M
(+13%)
Cap. Flow
+$8.37M
Cap. Flow % of AUM
Cap. Flow %
1.86%
Top 10 Holdings %
Top 10 Hldgs %
37.31%
Holding
345
New
52
Increased
98
Reduced
78
Closed
53
Avg Time Held
Equity + Options
2.9
years
Top 10 Avg Time Held
Equity + Options
0.9
years
Top 20 Avg Time Held
Equity + Options
1.6
years
Avg Time Held Equity only
2.9
years
Top 10 Avg Time Held Equity only
0.9
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ethos Technologies Inc
LIFE
|
+$4.48M |
| 2 |
Climb Global Solutions
CLMB
|
+$3.82M |
| 3 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$3.49M |
| 4 |
Freightos
CRGO
|
+$3.04M |
| 5 |
Elauwit Connection Inc
ELWT
|
+$630K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
M-tron Industries
MPTI
|
+$3.26M |
| 2 |
Aehr Test Systems
AEHR
|
+$2.03M |
| 3 |
Crexendo
CXDO
|
+$1.9M |
| 4 |
PERFECT MOMENT LTD
PMNT
|
+$1.11M |
| 5 |
Welltower
WELL
|
+$846K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.27% |
| 2 | Technology | 20.81% |
| 3 | Materials | 9.71% |
| 4 | Industrials | 6.91% |
| 5 | Consumer Staples | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
UnitedHealth
UNH
$353B
| $10.4K | ﹤0.01% |
25
+15
| +150% | +$5.56K |
2026 Q1
1 quarter
|
|
227
RTX Corp
RTX
$256B
| $10.2K | ﹤0.01% |
54
+32
| +145% | +$5.87K |
2026 Q1
1 quarter
|
|
228
ExxonMobil
XOM
$677B
| $10.1K | ﹤0.01% |
+74
| New | +$11.1K |
2026 Q2
0 quarters
|
|
229
Eli Lilly
LLY
$1.21T
| $9.6K | ﹤0.01% |
8
+6
| +300% | +$6.13K |
2026 Q1
1 quarter
|
|
230
Analog Devices
ADI
$176B
| $9.5K | ﹤0.01% |
24
+10
| +71% | +$3.96K |
2026 Q1
1 quarter
|
|
231
Excelerate Energy
EE
$1.16B
| $9.5K | ﹤0.01% |
250
| – | – |
2025 Q4
2 quarters
|
|
232
Progressive
PGR
$132B
| $9.21K | ﹤0.01% |
42
+31
| +282% | +$6.25K |
2025 Q4
2 quarters
|
|
233
Evolution Petroleum
EPM
$140M
| $9.2K | ﹤0.01% |
2,500
| – | – |
2013 Q2
52 quarters
|
|
234
Wells Fargo
WFC
$252B
| $8.76K | ﹤0.01% |
106
| – | – |
2025 Q4
2 quarters
|
|
235
Union Pacific
UNP
$172B
| $8.7K | ﹤0.01% |
32
+16
| +100% | +$4.2K |
2026 Q1
1 quarter
|
|
236
Lam Research
LRCX
$251B
| $8.67K | ﹤0.01% |
+20
| New | +$6.07K |
2026 Q2
0 quarters
|
|
237
OptimizeRx
OPRX
$165M
| $8.47K | ﹤0.01% |
1,480
| – | – |
2025 Q4
2 quarters
|
|
238
Monster Beverage
MNST
$89.5B
| $8.46K | ﹤0.01% |
+176
| New | +$7.4K |
2026 Q2
0 quarters
|
|
239
Global X Uranium ETF
URA
$4.47B
| $7.78K | ﹤0.01% |
178
+25
| +16% | +$1.27K |
2026 Q1
1 quarter
|
|
240
Caterpillar
CAT
$256B
| $7.46K | ﹤0.01% |
+7
| New | +$6.15K |
2026 Q2
0 quarters
|
|
241
PNC Financial Services
PNC
$89.5B
| $7.39K | ﹤0.01% |
+30
| New | +$6.72K |
2026 Q2
0 quarters
|
|
242
Mondelez International
MDLZ
$83.6B
| $7.06K | ﹤0.01% |
122
+74
| +154% | +$4.46K |
2026 Q1
1 quarter
|
|
243
IQVIA
IQV
$44.8B
| $6.76K | ﹤0.01% |
+35
| New | +$6.1K |
2026 Q2
0 quarters
|
|
244
McDonald's
MCD
$196B
| $6.76K | ﹤0.01% |
25
+12
| +92% | +$3.44K |
2026 Q1
1 quarter
|
|
245
Tesla
TSLA
$1.42T
| $6.73K | ﹤0.01% |
16
+15
| +1,500% | +$5.97K |
2025 Q4
2 quarters
|
|
246
Bioventus
BVS
$727M
| $6.68K | ﹤0.01% |
708
| – | – |
2025 Q4
2 quarters
|
|
247
DexCom
DXCM
$29.6B
| $6.47K | ﹤0.01% |
+96
| New | +$6.4K |
2026 Q2
0 quarters
|
|
248
TE Connectivity
TEL
$59.5B
| $6.45K | ﹤0.01% |
+32
| New | +$6.82K |
2026 Q2
0 quarters
|
|
249
iShares 0-3 Month Treasury Bond ETF
SGOV
$117B
| $6.44K | ﹤0.01% |
+64
| New | +$6.43K |
2026 Q2
0 quarters
|
|
250
CALL
Direxion Daily FTSE China Bull 3X ETF
YINN
$658M
| – | – |
0
| – | – |
2025 Q4
2 quarters
|
|
Similar funds
Bard Associates's Q2 2026 Portfolio in Review
As of Q2 2026, Bard Associates held 345 positions worth $451M, up 13% from $398M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Bard Associates's Q2 2026 filing shows 52 new, 98 increased, 78 reduced and 53 closed positions. Its largest new stake was Ethos Technologies Inc: 248,220 shares worth $4.5M. The largest sale was M-tron Industries, an estimated $3.26M.
By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 39% a quarter earlier, followed by Technology and Materials.
- Bard Associates's largest Q2 2026 buy was Ethos Technologies Inc: 248,220 shares worth $4.5M.
- Bard Associates added most to Climb Global Solutions in Q2 2026, an estimated $3.82M increase.
- Bard Associates's biggest Q2 2026 reduction was M-tron Industries, cutting an estimated $3.26M.
- Bard Associates fully exited PERFECT MOMENT LTD in Q2 2026, selling an estimated $1.11M.
- Bard Associates's ten largest holdings make up 37% of its $451M portfolio in Q2 2026.
- Bard Associates opened 52 new positions and closed 53 in Q2 2026.
- Bard Associates's portfolio value rose 13% quarter-over-quarter to $451M.
Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.